Breast neoplasms. Medical search

Tumors or cancer of the human BREAST.

Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.

Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.

Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females.

An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

Pathological processes of the BREAST.

The nursing of an infant at the breast.

New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.

Radiographic examination of the breast.

Neoplasms containing cyst-like formations or producing mucin or serum.

A cell line derived from cultured tumor cells.

A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.

Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.

Ability of neoplasms to infiltrate and actively destroy surrounding tissue.

Histochemical localization of immunoreactive substances using labeled antibodies as reagents.

Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.

A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.

Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.

Implants used to reconstruct and/or cosmetically enhance the female breast. They have an outer shell or envelope of silicone elastomer and are filled with either saline or silicone gel. The outer shell may be either smooth or textured.

Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.

Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.

Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.

The inspection of one's breasts, usually for signs of disease, especially neoplastic disease.

Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.

The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.

Tumors or cancer of the SKIN.

A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.

One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.

DNA present in neoplastic tissue.

A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.

Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)

Surgical procedure to remove one or both breasts.

An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)

Tumors or cancer of the LUNG.

Tumors or cancers of the KIDNEY.

A infiltrating (invasive) breast cancer, relatively uncommon, accounting for only 5%-10% of breast tumors in most series. It is often an area of ill-defined thickening in the breast, in contrast to the dominant lump characteristic of ductal carcinoma. It is typically composed of small cells in a linear arrangement with a tendency to grow around ducts and lobules. There is likelihood of axillary nodal involvement with metastasis to meningeal and serosal surfaces. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1205)

An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.

The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.

Tumors or cancer located in bone tissue or specific BONES.

Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.

Use of ultrasound for imaging the breast. The most frequent application is the diagnosis of neoplasms of the female breast.

Tumors or cancer of the THYROID GLAND.

Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.

A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human CHROMOSOME 17 at locus 17q21. Mutations of this gene are associated with the formation of HEREDITARY BREAST AND OVARIAN CANCER SYNDROME. It encodes a large nuclear protein that is a component of DNA repair pathways.

Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)

Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.

Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.

Substances that inhibit or prevent the proliferation of NEOPLASMS.

Tumors or cancer of the LIVER.

Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.

Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.

Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.

The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life.

An adenoma containing fibrous tissue. It should be differentiated from ADENOFIBROMA which is a tumor composed of connective tissue (fibroma) containing glandular (adeno-) structures. (From Dorland, 27th ed)

Tumors or cancer of the PAROTID GLAND.

Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.

Removal of only enough breast tissue to ensure that the margins of the resected surgical specimen are free of tumor.

A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)

Surgical reconstruction of the breast including both augmentation and reduction.

Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue.

Neoplasms associated with a proliferation of a single clone of PLASMA CELLS and characterized by the secretion of PARAPROTEINS.

A fluid-filled closed cavity or sac that is lined by an EPITHELIUM and found in the BREAST. It may appear as a single large cyst in one breast, multifocal, or bilateral in FIBROCYSTIC BREAST DISEASE.

Tumors or cancer of the APPENDIX.

A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.

Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.

The conic organs which usually give outlet to milk from the mammary glands.

Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.

Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.

Removal and examination of tissue obtained through a transdermal needle inserted into the specific region, organ, or tissue being analyzed.

All of the processes involved in increasing CELL NUMBER including CELL DIVISION.

One of the ESTROGEN RECEPTORS that has marked affinity for ESTRADIOL. Its expression and function differs from, and in some ways opposes, ESTROGEN RECEPTOR BETA.

A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)

Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.

Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.

Tumors or cancer of the ENDOCRINE GLANDS.

An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.)

Glandular tissue in the BREAST of human that is under the influence of hormones such as ESTROGENS; PROGESTINS; and PROLACTIN. In WOMEN, after PARTURITION, the mammary glands secrete milk (MILK, HUMAN) for the nourishment of the young.

A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.

The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.

The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.

Elements of limited time intervals, contributing to particular results or situations.

A malignant epithelial tumor with a glandular organization.

Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.

A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.

Neoplasms composed of vascular tissue. This concept does not refer to neoplasms located in blood vessels.

Tumors or cancer of the SALIVARY GLANDS.

Tumors or cancer of the EYE.

Tumors or cancer of the UTERUS.

Experimental transplantation of neoplasms in laboratory animals for research purposes.

Area of the human body underneath the SHOULDER JOINT, also known as the armpit or underarm.

The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.

Surgical insertion of an inert sac filled with silicone or other material to augment the female form cosmetically.

Tumors or cancer of the NOSE.

Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.

A large, nuclear protein, encoded by the BRCA2 gene (GENE, BRCA2). Mutations in this gene predispose humans to breast and ovarian cancer. The BRCA2 protein is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev. 2000;14(11):1400-6)

Tumors or cancer of the COLON.

An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)

The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.

Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.

The phosphoprotein encoded by the BRCA1 gene (GENE, BRCA1). In normal cells the BRCA1 protein is localized in the nucleus, whereas in the majority of breast cancer cell lines and in malignant pleural effusions from breast cancer patients, it is localized mainly in the cytoplasm. (Science 1995;270(5237):713,789-91)

RNA present in neoplastic tissue.

Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.

Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.

Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.

Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND.

A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.

Neoplasms composed of muscle tissue: skeletal, cardiac, or smooth. The concept does not refer to neoplasms located in muscles.

Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)

Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.

A benign epithelial tumor with a glandular organization.

Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.

The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.

A tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to breast and ovarian cancer. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6)

RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.

A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184)

A general term for various neoplastic diseases of the lymphoid tissue.

Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.

Tumors or cancer of the INTESTINES.

Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.

Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.

Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.

A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.

The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.

Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.

The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome.

Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.

Neoplasms composed of sebaceous or sweat gland tissue or tissue of other skin appendages. The concept does not refer to neoplasms located in the sebaceous or sweat glands or in the other skin appendages.

The erbB-2 gene is a proto-oncogene that codes for the erbB-2 receptor (RECEPTOR, ERBB-2), a protein with structural features similar to the epidermal growth factor receptor. Its name originates from the viral oncogene homolog (v-erbB) which is a truncated form of the chicken erbB gene found in the avian erythroblastosis virus. Overexpression and amplification of the gene is associated with a significant number of adenocarcinomas. The human c-erbB-2 gene is located at 17q21.2.

Neoplasms located in the vasculature system, such as ARTERIES and VEINS. They are differentiated from neoplasms of vascular tissue (NEOPLASMS, VASCULAR TISSUE), such as ANGIOFIBROMA or HEMANGIOMA.

Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.

The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.

Neoplasms composed of more than one type of neoplastic tissue.

Organized periodic procedures performed on large groups of people for the purpose of detecting disease.

Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.

Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.

Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.

The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)

Tumors or cancer of the PALATE, including those of the hard palate, soft palate and UVULA.

A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells.

The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.

A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)

Tumors or cancer of the MANDIBLE.

A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. (Stedman, 25th ed)

Tumors or cancer of the THYMUS GLAND.

Tumors or cancer of the SPLEEN.

Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Tumors or cancer of the BILE DUCTS.

Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.

The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.

The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.

A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972)

Persons who have experienced a prolonged survival after serious disease or who continue to live with a usually life-threatening condition as well as family members, significant others, or individuals surviving traumatic life events.

They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system.

One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.

Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.

The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.

Cancer or tumors of the MAXILLA or upper jaw.

Tomography using x-ray transmission and a computer algorithm to reconstruct the image.

In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.

Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.

A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)

Tumors or cancer of the anal gland.

In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.

Antibodies produced by a single clone of cells.

Tumors or cancer of the STOMACH.

Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.

The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.

Neoplasms composed of fatty tissue or connective tissue made up of fat cells in a meshwork of areolar tissue. The concept does not refer to neoplasms located in adipose tissue.

Any detectable and heritable alteration in the lineage of germ cells. Mutations in these cells (i.e., "generative" cells ancestral to the gametes) are transmitted to progeny while those in somatic cells are not.

A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.

The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.

A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.

Tumors or cancer of the DUODENUM.

Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.

Total mastectomy with axillary node dissection, but with preservation of the pectoral muscles.

An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Tumors or cancer of the MOUTH.

Using fine needles (finer than 22-gauge) to remove tissue or fluid specimens from the living body for examination in the pathology laboratory and for disease diagnosis.

Hybridization of a nucleic acid sample to a very large set of OLIGONUCLEOTIDE PROBES, which have been attached individually in columns and rows to a solid support, to determine a BASE SEQUENCE, or to detect variations in a gene sequence, GENE EXPRESSION, or for GENE MAPPING.

A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication.

Tumors or cancers of the ADRENAL CORTEX.

Carbohydrate antigen elevated in patients with tumors of the breast, ovary, lung, and prostate as well as other disorders. The mucin is expressed normally by most glandular epithelia but shows particularly increased expression in the breast at lactation and in malignancy. It is thus an established serum marker for breast cancer.

Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.

Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.

Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER.

Tumors or cancer of the MEDIASTINUM.

Tumors or cancer of the URINARY BLADDER.

Transplantation between animals of different species.

Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed)

A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)

A Janus kinase subtype that is involved in signaling from GROWTH HORMONE RECEPTORS; PROLACTIN RECEPTORS; and a variety of CYTOKINE RECEPTORS such as ERYTHROPOIETIN RECEPTORS and INTERLEUKIN RECEPTORS. Dysregulation of Janus kinase 2 due to GENETIC TRANSLOCATIONS have been associated with a variety of MYELOPROLIFERATIVE DISORDERS.

Neoplasms composed of cells from the deepest layer of the epidermis. The concept does not refer to neoplasms located in the stratum basale.

Diphtheria toxin effects on human cells in tissue culture. (1/42895)

HeLa cells exposed to a single sublethal concentration of diphtheria toxin were found to have diminished sensitivity when subsequently reexposed to the toxin. Three cells strains exhibiting toxin resistance were developed. In the cells that had previously been exposed to toxin at 0.015 mug/ml, 50% inhibition of protein synthesis required a toxin concentration of 0.3 mug/ml, which is more than 10 times that required in normal HeLa cells. There appears to be a threshold level of diphtheria toxin action. Concentrations of toxin greater than that required for 50% inhibition of protein synthesis (0.01 mug/ml) are associated with cytotoxicity, whereas those below this concentration may not be lethal. Several established human cell lines of both normal and neoplastic origin were tested for their sensitivity to the effects of the toxin. No special sensitivity was observed with the cells of tumor origin. Fifty % inhibition of protein synthesis of HeLa cells was achieved with diphtheria toxin (0.01 mug/ml) as compared to the normal human cell lines tested (0.03 and 0.5 mug/ml) and a cell line derived from a human pancreatic adenocarcinoma (0.2 mug/ml). A human breast carcinoma cell line showed a maximum of 45% inhibition of protein synthesis. This required a diphtheria toxin concentration of 5 mug/ml. These results suggest that different human cell lines show wide variation in their sensitivity to the toxin. (+info)

The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. (2/42895)

We have established or characterized six lines of human breast cancer maintained in long-term tissue culture for at least 1 year and have examined these lines for estrogen responsiveness. One of these cell lines, MCF-7, shows marked stimulation of macromolecular synthesis and cell division with physiological concentrations of estradiol. Antiestrogens are strongly inhibitory, and at concentrations greater than 3 X 10(-7) M they kill cells. Antiestrogen effects are prevented by simultaneous treatment with estradiol or reversed by addition of estradiol to cells incubated in antiestrogen. Responsive cell lines contain high-affinity specific estradiol receptors. Antiestrogens compete with estradiol for these receptors but have a lower apparent affinity for the receptor than estrogens. Stimulation of cells by estrogens is biphasic, with inhibition and cell death at concentrations of 17beta-estradiol or diethylstilbestrol exceeding 10(-7) M. Killing by high concentrations of estrogen is probably a nonspecific effect in that we observe this response with 17alpha-estradiol at equivalent concentrations and in the otherwise unresponsive cells that contain no estrogen receptor sites. (+info)

The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. (3/42895)

Glucocorticoids, at physiological concentration, inhibit cell division and thymidine incorporation in three lines of human breast cancer maintained in long-term tissue culture. At steroid concentrations sufficient to inhibit thymidine incorporation 50%, little or no effect is seen on protein synthesis 48 hr after hormone addition. All three of these lines are shown to have glucocorticoid receptors demonstrable by competitive protein binding assays. Receptors are extensively characterized in one line by sucrose density gradient analysis and binding specificity studies. Good correlation between receptor-binding specificity and biological activity is found except for progesterone, which binds to glucocorticoid receptor but is noninhibitory. Cross-competition and quantification studies demonstrate a separate receptor for progesterone. This receptor has limited binding specificities restricted largely to progestational agents, whereas the glucocorticoid receptor bound both glucocorticoids and progesterone. Two other human breast cancer lines neither contain glucocorticoid receptor nor are inhibited by glucocorticoids. It is concluded that in some cases glucocorticoids can directly limit growth in human breast cancer in vitro without requiring alterations in other trophic hormones. (+info)

The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture. (4/42895)

We have examined five human breast cancer cell lines in continuous tissue culture for androgen responsiveness. One of these cell lines shows a 2- to 4-fold stimulation of thymidine incorporation into DNA, apparent as early as 10 hr following androgen addition to cells incubated in serum-free medium. This stimulation is accompanied by an acceleration in cell replication. Antiandrogens [cyproterone acetate (6-chloro-17alpha-acetate-1,2alpha-methylene-4,6-pregnadiene-3,20-dione) and R2956 (17beta-hydroxy-2,2,17alpha-trimethoxyestra-4,9,11-triene-1-one)] inhibit both protein and DNA synthesis below control levels and block androgen-mediated stimulation. Prolonged incubation (greater than 72 hr) in antiandrogen is lethal. The MCF- cell line contains high-affinity receptors for androgenic steroids demonstrable by sucrose density gradients and competitive protein binding analysis. By cross-competition studies, androgen receptors are distinguishable from estrogen receptors also found in this cell line. Concentrations of steroid that saturate androgen receptor sites in vitro are about 1000 times lower than concentrations that maximally stimulate the cells. Changes in quantity and affinity of androgen binding to intact cells at 37 degrees as compared with usual binding techniques using cytosol preparation at 0 degrees do not explain this difference between dissociation of binding and effect. However, this difference can be explained by conversion of [3H]-5alpha-dihydrotestosterone to 5alpha-androstanediol and more polar metabolites at 37 degrees. An examination of incubation media, cytoplasmic extracts and crude nuclear pellets reveals probable conversion of [3H]testosterone to [3H]-5alpha-dihydrotestosterone. Our data provide compelling evidence that some human breast cancer, at least in vitro, may be androgen dependent. (+info)

Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530. (5/42895)

Elevated levels of Src kinase activity have been reported in a number of human cancers, including colon and breast cancer. We have analysed four human breast tumor cell lines that exhibit high levels of Src kinase activity, and have determined that these cell lines also exhibit a high level of a phosphotyrosine phosphatase activity that recognizes the Src carboxy-terminal P-Tyr530 negative regulatory site. Total Src kinase activity in these cell lines is elevated as much as 30-fold over activity in normal control cells and specific activity is elevated as much as 5.6-fold. When the breast tumor cells were grown in the presence of the tyrosine phosphatase inhibitor vanadate, Src kinase activity was reduced in all four breast tumor cell lines, suggesting that Src was being activated by a phosphatase which could recognize the Tyr530 negative regulatory site. In fractionated cell extracts from the breast tumor cells, we found elevated levels of a membrane associated tyrosine phosphatase activity that preferentially dephosphorylated a Src family carboxy-terminal phosphopeptide containing the regulatory tyrosine 530 site. Src was hypophosphorylated in vivo at tyrosine 530 in at least two of the tumor cell lines, further suggesting that Src was being activated by a phosphatase in these cells. In preliminary immunoprecipitation and antibody depletion experiments, we were unable to correlate the major portion of this phosphatase activity with several known phosphatases. (+info)

Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. (6/42895)

Increased breast cancer growth has been associated with increased expression of epidermal growth factor receptor (EGFR) and ErbB2 receptor tyrosine kinases (RTKs). Upon activation, RTKs may transmit their oncogenic signals by binding to the growth factor receptor bound protein-2 (Grb2), which in turn binds to SOS and activates the Ras/Raf/MEK/mitogen-activated protein (MAP) kinase pathway. Grb2 is important for the transformation of fibroblasts by EGFR and ErbB2; however, whether Grb2 is also important for the proliferation of breast cancer cells expressing these RTKs is unclear. We have used liposomes to deliver nuclease-resistant antisense oligodeoxynucleotides (oligos) specific for the GRB2 mRNA to breast cancer cells. Grb2 protein downregulation could inhibit breast cancer cell growth; the degree of growth inhibition was dependent upon the activation and/or endogenous levels of the RTKs. Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth. (+info)

Increased expression of fibroblast growth factor 8 in human breast cancer. (7/42895)

Fibroblast growth factor 8 (FGF8) is an important developmental protein which is oncogenic and able to cooperate with wnt-1 to produce mouse mammary carcinoma. The level of expression of FGF8 mRNA was measured in 68 breast cancers and 24 non-malignant breast tissues. Elevated levels of FGF8 mRNA were found in malignant compared to non-malignant breast tissues with significantly more malignant tissues expressing FGF8 (P=0.019) at significantly higher levels (P=0.031). In situ hybridization of breast cancer tissues and analysis of purified populations of normal epithelial cells and breast cancer cell lines showed that malignant epithelial cells expressed FGF8 mRNA at high levels compared to non-malignant epithelial and myoepithelial cells and fibroblasts. Although two of the receptors which FGF8 binds to (FGFR2-IIIc, FGFR3-IIIc) are not expressed in breast cancer cells, an autocrine activation loop is possible since expression of fibroblast growth factor receptor (FGFR) 4 and FGFR1 are retained in malignant epithelial cells. This is the first member of the FGF family to have increased expression in breast cancer and a potential autocrine role in its progression. (+info)

Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells. (8/42895)

Loss of p53 function by mutational inactivation is the most common marker of the cancerous phenotype. Previous studies from our laboratory have demonstrated 17 beta estradiol (E2) induction of p53 protein expression in breast cancer cells. Although direct effects of E2 on the expression of p53 gene are not known, the steroid is a potent regulator of c-Myc transcription. In the present studies, we have examined the ability of E2 and antiestrogens to regulate the P1 promoter of the p53 gene which contains a c-Myc responsive element. Estrogen receptor (ER)-positive T47D and MCF-7 cells were transiently transfected with the P1CAT reporter plasmid and levels of CAT activity in response to serum, E2 and antiestrogens were monitored. Factors in serum were noted to be the dominant inducers of chloramphenicol acetyltransferase (CAT) expression in MCF-7 cells. The levels of CAT were drastically reduced when cells were maintained in serum free medium (SFM). However, a subtle ER-mediated induction of CAT expression was detectable when MCF-7 cells, cultured in SFM, were treated with E2. In serum-stimulated T47D cells, the CAT expression was minimal. The full ER antagonist, ICI 182 780 (ICI) had no effect. Treatment with E2 or 4-hydroxy tamoxifen (OHT) resulted in P1CAT induction; OHT was more effective than E2. Consistent with c-Myc regulation of the P1 promoter, E2 stimulated endogenous c-Myc in both cell lines. Two forms of c-Myc were expressed independent of E2 stimuli. The expression of a third more rapidly migrating form was E2-dependent and ER-mediated since it was blocked by the full ER antagonist, ICI, but not by the ER agonist/antagonist OHT. These data demonstrate both ER-mediated and ER-independent regulation of c-Myc and the P1 promoter of the p53 gene, and show differential effects of the two classes of antiestrogens in their ability to induce the P1 promoter of the p53 gene in breast cancer cells. (+info)

Margolese RG, Fisher B, Hortobagyi GN, Bloomer WD (2000). "Neoplasms of the Breast". In Bast RC, Kufe DW, Pollock RE, et al. ( ... Mainly taken from risk factors for breast cancer, risk factors can be described in terms of, for example: Relative risk, such ... Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN (July 2004). "Breast carcinoma in men: a population-based study". ... of breast cancer cases are diagnosed in women." Increase in incidence in the exposed group, such as "each daily alcoholic ...

https://en.wikipedia.org/wiki/Risk_factor

Erratum for "Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms"". Science. 259 ( ... 1990). "Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms". Science. 250 (4985): ... Li F.P.; Fraumeni J.F. (October 1969). "Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?". Ann. ... at least one first or second degree relative with an LFS tumour (except breast cancer if the proband has breast cancer) before ...

https://en.wikipedia.org/wiki/Li-Fraumeni_syndrome

These were cancers of the brain, lung, bowel, breast, and bladder, and other neoplasms. Not only are benzodiazepines associated ... Breast feeding by mothers using nitrazepam is not recommended. Nitrazepam is a long-acting benzodiazepine with a risk of drug ... Nitrazepam rapidly crosses the placenta and is present in breast milk in high quantities. Therefore, benzodiazepines including ...

https://en.wikipedia.org/wiki/Nitrazepam

Breast cysts (as occur commonly during pregnancy and at other times) are another example, as are other encapsulated glandular ... ICD-10 classifies neoplasms into four main groups: benign neoplasms, in situ neoplasms, malignant neoplasms, and neoplasms of ... The term 'neoplasm' is a synonym of "tumor". 'Neoplasia' denotes the process of the formation of neoplasms/tumors, the process ... "II Neoplasms". World Health Organization. Retrieved 19 June 2014.. *^ a b Abrams, Gerald. "Neoplasia I". Retrieved 23 January ...

https://en.wikipedia.org/wiki/Tumours

Neoplasms of the Lung Chapter 75: Breast Cancer Chapter 76: Upper Gastrointestinal Tract Cancers Chapter 77: Lower ... Fine Needle Aspiration of Breast Cyst Chapter CP11: Clinical Procedures Tutorial: IV Insertion Chapter CP12: Clinical ... Polycythemia Vera and Other Myeloproliferative Neoplasms Chapter 100: Acute Myeloid Leukemia Chapter 101: Chronic Myeloid ...

https://en.wikipedia.org/wiki/Harrison's_Principles_of_Internal_Medicine

", "breast cancer" to "breast neoplasms". Where appropriate, these MeSH terms are automatically "expanded", that is, include ...

https://en.wikipedia.org/wiki/PubMed_Identifier

Excessive activation of LIM-kinase is displayed in breast cancer. Breast tumor cells with suppressed expression of the LIM- ... The factors limiting the growth of malignant neoplasm include the basal membrane and various components of the surrounding ... of all histological types of breast cancer. Despite the considerable structural diversity of the primary breast tumor, five ... For example, breast tumor cells detached from the solid mass gain the ability to invade lymphatic vessels. Currently, two ...

https://en.wikipedia.org/wiki/Invasion_(cancer)

It also confirms the genetic heterogeneity between the primary neoplasm of breast cancer patients and their respective ... 2003). Models of Breast Cancer: quo vadis, animal modeling? Breast Cancer Research 6(31), 31-38.doi: 10.1186/bcr723 Pulaski BA ... Fantozzi, A; Christofori, G (2006). "Mouse models of breast cancer metastasis". Breast Cancer Research. 8 (4): 212. doi:10.1186 ... Mice may not be an ideal model for breast cancer. This is mainly due to the lack of precision in many of the models. When ...

https://en.wikipedia.org/wiki/Mouse_models_of_breast_cancer_metastasis

A urogenital neoplasm is a tumor of the urogenital system. Types include: Cancer of the breast and female genital organs: ( ... Breast cancer, Vulvar cancer, Vaginal cancer, Vaginal tumors, Cervical cancer, Uterine cancer, Endometrial cancer, Ovarian ...

https://en.wikipedia.org/wiki/Urogenital_neoplasm

... hCG was discovered to be expressed in certain kinds of malignant neoplasms, including breast cancer, adenocarcinoma of the ... Agnantis, NJ; F Patra; L Khaldi; S Filis (1992). "Immunohistochemical expression of subunit beta HCG in breast cancer". Eur J ...

https://en.wikipedia.org/wiki/Immunocontraception

In 2009, an update including 5 more years (up to 1996) found an increase in "lymphatic and hematopoietic tissue neoplasms" and ... increased breast cancer.[11]. The male children of mothers who were, during pregnancy of those children, exposed to high levels ...

https://en.m.wikipedia.org/wiki/Seveso_disaster

... and clinical evidence of malignant pDC infiltrations in the breasts, eyes, kidneys, lungs, gastrointestinal tract, bone, ... The neoplasm occurs in individuals of all ages but predominates in the elderly; in children, it afflicts males and females ... Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy. It was initially regarded as a form of ... Blastic plasmacytoid dendritic cell neoplasm is an aggressive malignancy with features of cutaneous lymphoma (e.g. malignant ...

https://en.wikipedia.org/wiki/Blastic_plasmacytoid_dendritic_cell_neoplasm

A study of 93 patients with incurable neoplasms". J Natl Med Assoc. 43 (4): 211-240. PMC 2616951. PMID 14850976.. ... In 1951, Jane C. Wright demonstrated the use of methotrexate in solid tumors, showing remission in breast cancer.[35] Wright's ... It is effective for the treatment of a number of cancers, including: breast, head and neck, leukemia, lymphoma, lung, ... Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, and osteosarcoma.[1] Types of ...

https://en.m.wikipedia.org/wiki/Methotrexate

breast cancer metastasis neoplasm chemotherapy Mouse models of breast cancer metastasis Phyllodes tumour "Secondary (metastatic ... advanced breast cancer, secondary tumours, secondaries or stage 4 breast cancer, is a stage of breast cancer where the disease ... Breast Cancer Res Treat 2015. Lee, YT (July 1983). "Breast carcinoma: pattern of metastasis at autopsy". Journal of Surgical ... Metastatic breast cancer cells frequently differ from the preceding primary breast cancer in properties such as receptor status ...

https://en.wikipedia.org/wiki/Metastatic_breast_cancer

For example, the most common type of breast cancer is called ductal carcinoma of the breast. Here, the adjective ductal refers ... They form a subset of neoplasms. A neoplasm or tumor is a group of cells that have undergone unregulated growth and will often ... Radiation to the breast reduces the ability of that breast to produce milk and increases the risk of mastitis. Also, when ... for breast cancer, see Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, et al. (February 2009). "Breast ...

https://en.wikipedia.org/wiki/Malignant_neoplasms

... (CIS), also known as in situ neoplasm, is a group of abnormal cells.[1][2] While they are a form of neoplasm[ ... This controversy also depends on the exact CIS in question (i.e. cervical, skin, breast). Some authors do not classify them as ... Rather, the lesion is flat (in the skin, cervix, etc.) or follows the existing architecture of the organ (in the breast, lung, ... Other forms require major surgery, the best known being intraductal carcinoma of the breast (also treated with radiotherapy). ...

https://en.wikipedia.org/wiki/Carcinoma_in_situ

... s are neoplasms located in the spinal cord. Extradural tumors are more common than intradural neoplasms. Depending ... commonly breast, prostate and lung cancer). Intradural tumours can be classified as intramedullary (within the spinal ...

https://en.wikipedia.org/wiki/Spinal_tumor

Lung cancer, breast cancer and melanoma patients were found to be at the highest risk of developing brain metastases. However, ... Neoplasm Metastasis Cancer Brain tumor Tse V (10 November 2009). "Brain Metastasis". Medscape. Retrieved 13 January 2010. " ... The most common sites of primary cancer which metastasize to the brain are lung, breast, colon, kidney, and skin cancer. Brain ... However, some cancers such as lymphomas, small cell lung carcinomas (SCLC) and breast cancer may be highly chemosensitive and ...

https://en.wikipedia.org/wiki/Brain_metastasis

EMH in the lymph nodes is usually associated with underlying hematopoietic neoplasms. Myeloproliferative neoplasms (MPNs) tend ... The following tissues may also be associated with EMH: thymus, heart, breast, prostate, fatty tissue, adrenal glands, kidney, ... Other manifestations occur in the thymus, heart, breast, prostate, broad ligaments, kidneys, adrenal glands, pleura, ... breast, cervix, nasal sinus, mediastinum and brain. Of the various organs associated with EMH, the spleen offers a unique site ...

https://en.wikipedia.org/wiki/Extramedullary_hematopoiesis

Rarer forms of tubal neoplasm include leiomyosarcoma, and transitional cell carcinoma. As the tumor is often enmeshed with the ... and the breast. A pelvic examination may detect an adnexal mass. A CA-125 blood test is a nonspecific test that tends to be ... Primary fallopian tube cancer (PFTC), often just tubal cancer, is a malignant neoplasm that originates from the fallopian tube ...

https://en.wikipedia.org/wiki/Fallopian_tube_cancer

It is also used to treat breast development and small penis in males. It is typically given as a gel for application to the ... Dao TL (1975). "Pharmacology and Clinical Utility of Hormones in Hormone Related Neoplasms". In Sartorelli AC, Johns DJ (eds ... Androstanolone was found to be effective in the treatment of advanced breast cancer in women in the 1950s, although it was used ... Segaloff A, Horwitt BN, Cakabasi RA, Murison PJ, Osser JV (1955). "Hormonal therapy in cancer of the breast.VIII. The effect of ...

https://en.wikipedia.org/wiki/Androstanolone

A mammary tumor is a neoplasm originating in the mammary gland. It is a common finding in older female dogs and cats that are ... Szabo S, Haislip A, Garry R (2005). "Of mice, cats, and men: is human breast cancer a zoonosis?". Microsc Res Tech. 68 (3-4): ... There are many differences between mammary tumors in animals and breast cancer in humans, including tumor type, malignancy, and ... Benjamin S, Lee A, Saunders W (1999). "Classification and behavior of canine mammary epithelial neoplasms based on life-span ...

https://en.wikipedia.org/wiki/Mammary_tumor

... s are sometimes called breast mice or a breast mouse owing to their high mobility in the breast. Fibroadenomas are ... These tumors characteristically display hypovascular stroma compared to malignant neoplasms. Furthermore, the epithelial ... breast cancer. Complex fibroadenomas may increase the risk of breast cancer. In the male breast, fibroepithelial tumors are ... Fibroadenomas are benign breast tumours characterized by an admixture of stromal and epithelial tissue. Breasts are made of ...

https://en.wikipedia.org/wiki/Fibroadenoma

The two most common cancers that spread to the eye from another organ are breast cancer and lung cancer. Other less common ... Eye neoplasms can affect all parts of the eye, and can be a benign tumor or a malignant tumor (cancer). Eye cancers can be ... Retrieved from "https://en.wikipedia.org/w/index.php?title=Eye_neoplasm&oldid=895356793" ...

https://en.m.wikipedia.org/wiki/Eye_neoplasm

... for breast cancer after breast-conserving surgery, radiotherapy has been found to halve the rate at which the disease recurs.[7 ... Hypopituitarism commonly develops after radiation therapy for sellar and parasellar neoplasms, extrasellar brain tumours, head ... "Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of ... 2005). "Breast cancer". In Gerbaulet A, Pötter R, Mazeron J, Limbergen EV (eds.). The GEC ESTRO handbook of brachytherapy. ...

https://en.wikipedia.org/wiki/Radiation_

The gene that codes for FAS has been investigated as a possible oncogene.[35] FAS is upregulated in breast cancers and as well ... in ovarian neoplasms predicts shorter survival". Hum. Pathol. 28 (6): 686-92. doi:10.1016/S0046-8177(97)90177-5. PMID 9191002. ... "MRNA stability and overexpression of fatty acid synthase in human breast cancer cell lines". Anticancer Res. 27 (1A): 27-34. ...

https://en.wikipedia.org/wiki/Fatty_acid_synthase

Wang S, Wang X, Liu M, Bai O (April 2018). "Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel ... and similar abnormalities in breasts, eyes, kidneys, lungs, gastrointestinal tract, bone, sinuses, ears, and/or testes. The ... Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare type of myeloid cancer in which malignant pDCs infiltrate the ... pDCs that undergo malignant transformation cause a rare hematologic disorder, blastic plasmacytoid dendritic cell neoplasm. In ...

https://en.wikipedia.org/wiki/Plasmacytoid_dendritic_cell

... familial Pancreatic diseases Pancreatic islet cell neoplasm Pancreatic islet cell tumors Pancreatic lipomatosis duodenal ... syndrome Paget disease extramammary Paget disease juvenile type Paget's disease of bone Paget's disease of the breast Paget's ... et varioliformis acuta Pityriasis rubra pilaris Piussan-Lenaerts-Mathieu syndrome Placenta disorder Placenta neoplasm Placental ... retardation-hyperkeratosis Parapsoriasis Parasitophobia Parastremmatic dwarfism Parathyroid cancer Parathyroid neoplasm ...

https://en.wikipedia.org/wiki/List_of_diseases_(P)

Such mutations and epigenetic alterations can give rise to cancer (see malignant neoplasms). Thus, CpG island hyper/hypo- ... FEN1 is over-expressed in the majority of cancers of the breast, prostate, stomach, neuroblastomas, pancreatic, and lung. DNA ... "Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers". Mol. Cancer Res. 6 (11): 1710-7. ...

https://en.wikipedia.org/wiki/CpG_site

Neoplasms will often show as differently colored masses (also referred to as processes) in CT or MRI results. ... breast cancer, malignant melanoma, kidney cancer, and colon cancer (in decreasing order of frequency). ... The skull bone structure can also be subject to a neoplasm that by its very nature reduces the volume of the intracranial ... "CNS and Miscellaneous Intracranial and Intraspinal Neoplasms" (PDF). SEER Pediatric Monograph. National Cancer Institute. pp. ...

https://en.m.wikipedia.org/wiki/Brain_tumors

Myxomas may also occur outside the heart, usually in the skin and breast. Endocrine tumors may manifest as disorders such as ... Epithelioid blue nevus List of cutaneous neoplasms associated with systemic syndromes Carney Syndrome at eMedicine Carney, J.; ... "Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new association". J Clin Endocrinol Metab. 96 (11): ...

https://en.wikipedia.org/wiki/Carney_complex

Isabel Woodman, "Breast feeding reduces risk of breast cancer, says study," British Medical Journal, v.); Jul 27, 2002 ... Several severe adverse health effects, such as an increased incidence of cancers, thyroid diseases, CNS neoplasms, and possibly ... The increased radiosensitivity of certain organs in women, such as the breast, ovaries, and thyroid is likely the cause of this ... As increasing concerns are raised regarding the environmental risks related to breast, it is interesting to note that the BEIR ...

https://en.wikipedia.org/wiki/Downwinders

Salivary gland neoplasm. *Sarcoma. *Skin cancer. *Small intestine cancer. *Small-cell carcinoma ...

https://simple.wikipedia.org/wiki/Category:Cancer

... particularly for breast cancer. The difference between breast cancer recurrence in patients who receive radiotherapy vs. those ... Hypopituitarism commonly develops after radiation therapy for sellar and parasellar neoplasms, extrasellar brain tumours, head ... 2005). "Breast cancer". In Gerbaulet A, Pötter R, Mazeron J, Limbergen EV. The GEC ESTRO handbook of brachytherapy. Belgium: ... Brachytherapy is commonly used as an effective treatment for cervical,[66] prostate,[67] breast,[68] and skin cancer[69] and ...

https://en.wikipedia.org/wiki/Radiation_therapy

Mutations in BRCA1 and BRCA2, important risk factors for ovarian cancer and breast cancer in women, have also been implicated ... "Male Genitals - Prostate Neoplasms". Pathology study images. University of Virginia School of Medicine. Archived from the ... "Breast cancer receives much more research funding, publicity than prostate cancer despite similar number of victims". The Daily ... It also discovered that the waiting time between referral and diagnosis was two weeks for breast cancer but three months for ...

https://fa.wikipedia.org/wiki/سرطان_پروستات?match=en

Chronically insufficient intake of folic acid may increase the risk of colorectal, breast, ovarian, pancreas, brain, lung, ... Folate deficiency hinders DNA synthesis and cell division, affecting hematopoietic cells and neoplasms the most because of ...

https://en.wikipedia.org/wiki/Vitamin_b9

cystic neoplasms: Serous microcystic adenoma. *Intraductal papillary mucinous neoplasm. *Mucinous cystic neoplasm ... Paget's disease of the breast / Extramammary Paget's disease. Lobular carcinoma. *Lobular carcinoma in situ ...

https://en.wikipedia.org/wiki/Gastrointestinal_carcinoid_tumor

Secondary neoplasm[edit]. Development of secondary neoplasia after successful chemotherapy or radiotherapy treatment can occur ... A woman being treated with docetaxel chemotherapy for breast cancer. Cold mittens and wine coolers are placed on her hands and ... The most common secondary neoplasm is secondary acute myeloid leukemia, which develops primarily after treatment with ... primarily estrogens for breast cancer and androgens for prostate cancer) is known as hormonal therapy, while the inhibition of ...

https://en.wikipedia.org/wiki/Chemotherapeutics

FEN1 is over-expressed in the majority of cancers of the breast,[32] prostate,[33] stomach,[34][35] neuroblastomas,[36] ... see malignant neoplasms). Thus, CpG island hyper/hypo-methylation in the promoters of DNA repair genes are likely central to ... "Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers". Mol. Cancer Res. 6 (11): 1710-7. ...

https://en.wikipedia.org/wiki/CpG_island

"Neoplasms and cancer" has been chosen to reflect the fact that not all tumours are benign. The word "cancer" has been included ... Template:Breast navs(edit talk links history). *Template:Cell navs(edit talk links history) ...

https://kn.wikipedia.org/wiki/ಟೆಂಪ್ಲೇಟು:Central_nervous_system_navs

Breast: Nearly all breast cancers are ductal carcinoma.. *Prostate: The most common form of carcinoma of the prostate is ... 8560-8580) Complex epithelial neoplasms. Carcinoma In situ[edit]. The term carcinoma in situ (or CIS) is a term for cells that ... For example, the colon[19] and bladder cancer[20] staging system relies on depth of invasion, staging of breast carcinoma is ... and imaging studies in a logical fashion to obtain information about the size of the neoplasm and the extent of its invasion ...

https://en.wikipedia.org/wiki/Carcinomas

"Photon-counting breast CT measures up". medicalphysicsweb. Archived from the original on 27 July 2016. Retrieved 28 July 2016. ... superior information as compared to CT scans when seeking information about headache to confirm a diagnosis of neoplasm, ... Some early research has found the dose reduction potential of photon counting CT for breast imaging to be very promising.[116] ...

https://en.m.wikipedia.org/wiki/X-ray_computed_tomography

The skull bone structure can also be subject to a neoplasm that by its very nature reduces the volume of the intracranial ... breast cancer, malignant melanoma, kidney cancer, and colon cancer (in decreasing order of frequency). ... "CNS and Miscellaneous Intracranial and Intraspinal Neoplasms" (PDF). SEER Pediatric Monograph. National Cancer Institute. pp. ... More generally a neoplasm may cause release of metabolic end products (e.g., free radicals, altered electrolytes, ...

https://en.m.wikipedia.org/wiki/Brain_tumor

For instance, CMF-therapy for breast cancer (where the cumulative dose is typically less than 20 grams of cyclophosphamide) ... Bernatsky S, Clarke AE, Suissa S (February 2008). "Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis ... breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.[4] As an immune suppressor it is used in nephrotic syndrome ... Myeloproliferative neoplasms, including acute leukemia, non-Hodgkin lymphoma and multiple myeloma, occurred in 5 of 119 ...

https://en.m.wikipedia.org/wiki/Cyclophosphamide

The authors also found that EMT can happen in breast cancer cell lines with hypermethylation of CDH1 promoter, but in breast ... Neoplasm: Tumor suppressor genes/proteins and Oncogenes/Proto-oncogenes. Ligand. Growth factors. ... Inactivation of CDH1 (accompany with loss of the wild-type allele) in 56% of lobular breast carcinomas.[54][55] ... Hajra KM, Chen DY, Fearon ER (March 2002). "The SLUG zinc-finger protein represses E-cadherin in breast cancer". Cancer ...

https://en.wikipedia.org/wiki/CDH1_

en:Neoplasm (40) → 신생물 *en:Nephrotic syndrome (38) → 신증후군 *en:Nervous system disease (4) ... en:Breast cancer screening (2). *en:Breathing gas (17). *en:Bronchiectasis (33) → 기관지확장증 ...

https://ko.m.wikipedia.org/wiki/위키백과:미번역_문서/의학

টেমপ্লেট:Diseases of the pelvis, genitals and breasts *দে. *স. যৌনবাহিত সংক্রমণ অথবা যৌনব্যাধি-সংক্রান্ত রোগ (STD and STI) ( ...

https://bn.wikipedia.org/wiki/শ্রোণীর_প্রদাহ_রোগ

... s are sometimes called breast mice or a breast mouse owing to their high mobility in the breast.[3] ... These tumors characteristically display hypovascular stroma compared to malignant neoplasms.[2][12][9] Furthermore, the ... Not to be confused with Fibrocystic breast changes.. Fibroadenomas are benign breast tumours characterized by an admixture of ... Since both fibroadenomas, and breast lumps as a sign of breast cancer can appear similar, it is recommended to perform ...

https://en.m.wikipedia.org/wiki/Fibroadenoma

... breast cancer that has spread to the lung is called metastatic breast cancer. Metastases often have a characteristic round ... Horn, L; Lovly, CM; Johnson, DH (2015). "Chapter 107: Neoplasms of the lung". In Kasper, DL; Hauser, SL; Jameson, JL; Fauci, AS ... This makes it the most common cause of cancer-related death in men and second most common in women after breast cancer.[19] The ... and is second after breast cancer in mortality. In 2012, there were 1.82 million new cases globally, and 1.56 million deaths ...

https://en.wikipedia.org/wiki/Lung_cancer

https://en.m.wikipedia.org/wiki/Radiotherapy

Lung cancer is an extremely heterogeneous family of malignant neoplasms,[1] with well over 50 different histological variants ... similar to breast carcinomas[32] However, it is at present unknown whether blockade of these receptors affects the growth of c- ...

https://en.wikipedia.org/wiki/Targeted_therapy_of_lung_cancer

Srikumar Chakravarthi; Baba Krishnan; Malathy Madhavan (1999). "Apoptosis and expression of p53 in colorectal neoplasms". ... "Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: ... As summarized in the articles Carcinogenesis and Neoplasm, for sporadic cancers in general, a deficiency in DNA repair is ...

https://en.m.wikipedia.org/wiki/Colon_cancer

Glandular and epithelial neoplasms (ICD-O 8010-8589). Epithelium. Papilloma/carcinoma. (8010-8139). *Small cell carcinoma ... Paget's disease of the breast / Extramammary Paget's disease. Lobular carcinoma. *Lobular carcinoma in situ ...

https://en.wikipedia.org/wiki/Somatostatinoma

Diseases of the skin include skin infections and skin neoplasms (including skin cancer).[28] ... Mammillated: with rounded, breast-like projections. *Reticular or reticulated: resembling a net ...

https://en.wikipedia.org/wiki/Cutaneous_conditions

Adipose tissue neoplasm. *Adiposis dolorosa. *Adiposogenital dystrophy. *Adipsia. *Adjustment disorder. *Adnexal and skin ...

https://en.wikipedia.org/wiki/Category:Infobox_medical_condition_

breast neoplasms. *tamoxifen, pharmacology and therapeutic use. *tamoxifen, antagonists and inhibitors. *cytochrome P-450 2D6 ... Using the Danish Breast Cancer Cooperative Group Registry, we identified 366 cases with local or distant breast cancer ... No Increase in Breast Cancer Recurrence with Concurrent Use of Tamoxifen and Some CYP2D6-Inhibiting Medications. Thomas P. ... We computed the breast cancer recurrence odds ratio (OR) and 95% confidence interval for each medication. The pooled recurrence ...

http://cebp.aacrjournals.org/content/early/2009/08/14/1055-9965.EPI-09-0516

Breast Neoplasms 12 complications 9 Breast 9 Cancer 6 methods 5 Complications more ... 5 prevention & control 4 Treatment 4 ... Bone Neoplasms 1 Bone metastasis 1 Classification 1 Cognitive Behavioral Therapy 1 Colon (Anatomy) 1 Colorectal Neoplasms 1 ... Showing 1 - 12 results of 12 for search Breast Neoplasms complications. Skip to content Breast Neoplasms complications., query time: 0.35s ...

https://i-share.carli.illinois.edu/all/vf-lac/Search/Results?lookfor=%22Breast+Neoplasms+complications.%22&type=Subject

Your purchase of our Breast Cancer cell is supporting NBCFs early detection, education and support services.,br,,br,10% of the ... Breast Cancer affects 1 in every 8 women, but early detection and proper screening can help ensure the best outcomes. This ... Breast Cancer (Malignant neoplasm). Breast Cancer (Malignant neoplasm) GMUS-PD-0104 $8.95 ... All about Breast Cancer (Malignant neoplasm). FACTS: Breast cancer usually begins as a lump that can be seen in a mammogram or ...

https://www.giantmicrobes.com/us/products/breastcancer.html

Neoplasms of the Breast - Breast cancer is the most common malignancy in women in the United States, with more than 180,000 ... Breast Cancer definition, Diagnosis and Staging, Differential Diagnosis, Treatment and Management. ... And when this process takes place in the breast, its breast cancer. Tumors in the breast tend to grow slowly; by the time a ... What is breast cancer?. Jan 10.2012 Breast cancer is a disease in which malignant (cancer) cells form in the tissues of the ...

http://www.health.am/cr/breast-cancer/

... and medullary neoplasms are three common forms of breast cancer. These tumors are differentiated by location and require ... Breast density: Breasts are considered "dense" when there is a high ratio of tissue to fat. Women with dense breasts are more ... Cystic, Mucinous & Serous Neoplasms. Dermoid Cyst. Desmoplastic Small Round Cell Tumor. Ductal, Lobular & Medullary Neoplasms. ... Ductal, lobular, and medullary neoplasms are three of the main types of breast cancer. ...

http://www.knowcancer.com/oncology/ductal-lobular-and-medullary-neoplasms/

Search of: Recruiting, Not yet recruiting, Available Studies , Inflammatory Breast Neoplasms - Modify Search. Fill in any or ...

https://clinicaltrials.gov/ct2/results/refine?recr=Open&cond=%22Inflammatory+Breast+Neoplasms%22

disease or metastatic breast.. - Must be appropriate to receive endocrine therapy as treatment for advanced disease. ( ... In Postmenopausal Women With Locally Advanced Or Metastatic Breast Cancer. Trial Phase:. Phase 2. Minimum Age:. 18 Years. ... In Postmenopausal Women With Locally Advanced Or Metastatic Breast Cancer ...

http://www.knowcancer.com/cancer-trials/NCT00062751/

This a subset of snomed-ct regarding neoplasm and hamartoma, based on Snomed clinical practices used terms (Fondazione S. ...

https://bioportal.bioontology.org/ontologies/SNMD_BC

Male Breast Neoplasms anonymous support group with inform... ... people sharing true stories in the I Have Male Breast Neoplasms ... Do You Have Male Breast Neoplasms? Join friendly ... I Have Male Breast Neoplasms does not have any stories yet. Be ... Male Breast Neoplasms anonymous support group with information on diagnosis, treatment, symptoms, along with personal stories ... and experiences with Male Breast Neoplasms. Youre not alone. Report Group. ...

http://www.experienceproject.com/groups/Have-Male-Breast-Neoplasms/98618

Study of Hypofractionated Partial Breast Irradiation in Women With Early Stage Breast Cancer. *Malignant Neoplasm of Breast ... Comparison of the Breast Tumor Microenvironment. *Triple Negative Breast Cancer. *Hormone Receptor Positive Malignant Neoplasm ... Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR. *Breast Neoplasms ... Phase 1 Study of DS-8201a in HER-2 Breast Cancer Patients. *Malignant Neoplasm of Breast ...

https://clinicaltrials.gov/ct2/results?recr=open&cond=%22Breast+Neoplasms%22+AND+%22Breast+Diseases%22&show_down=Y

Trastuzumab Completed Phase 1 Trials for Neoplasms, Breast Treatment. Back to Trastuzumab ... MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer. *Trastuzumab ( ... A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer. *Trastuzumab (DB00072) ... in Patients With HER2-positive Advanced Breast Cancer.. *Afatinib (DB08916) ...

https://www.drugbank.ca/drugs/DB00072/clinical_trials?conditions=DBCOND0030201&phase=1&purpose=treatment&status=completed

The observed bimodal patterns of breast cancer incidence in the U.S. suggested that breast cancer may be viewed as more than ... Leukocyte telomere length, breast cancer risk in the offspring: the relations with fathers age at birth. Arbeev, Konstantin ... Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms. Kravchenko, J; Akushevich, Igor; ... Optimized approach to decision fusion of heterogeneous data for breast cancer diagnosis. Jesneck, JL; Nolte, LW; Baker, JA; ...

https://dukespace.lib.duke.edu/dspace/browse?type=subject&value=Breast%20Neoplasms

Breast Neoplasms (Breast Cancer). 2/2016. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian ... Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study.. ... Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.. ... Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.. ...

http://www.curehunter.com/public/authorSummary-Zheng,%20Wei.do?keywordId=D001943

Trastuzumab Terminated Phase 2 Trials for Cancer, Breast / Neoplasms Metastasis Treatment. Back to Trastuzumab ... Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery. *Everolimus ( ... A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer. ... Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer. *Trastuzumab ...

https://www.drugbank.ca/drugs/DB00072/clinical_trials?conditions=DBCOND0054116%2CDBCOND0066909&phase=2&purpose=treatment&status=terminated

Find out information about Breast neoplasms. cancer cancer, in medicine, common term for neoplasms, or tumors, that are ... Like benign tumors, malignant tumors do not respond to body mechanisms... Explanation of Breast neoplasms ... OR breast neoplasms [Figure/Table Caption] OR breast neoplasms[Body - All Words] OR breast neoplasms[Title] OR breast neoplasms ... breast cancer. (redirected from Breast neoplasms). Also found in: Dictionary, Thesaurus, Medical. breast cancer,. cancercancer, ...

https://encyclopedia2.thefreedictionary.com/Breast+neoplasms

Breast Neoplasms (Breast Cancer). 11/2015. Response to preoperative endocrine therapy in breast cancer patients can alter ... Spotlight on neoadjuvant therapy for breast cancer.. 5/2015. Surgical Considerations After Neoadjuvant Chemotherapy: Breast ... Utilization and Outcomes of Breast Brachytherapy in Younger Women.. 8/2015. GATA-binding protein 3 enhances the utility of ... Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult ...

http://www.curehunter.com/public/authorSummary-Hunt,%20Kelly%20K.do?keywordId=D001943

Breast cancer and other second neoplasms after childhood Hodgkins disease. Bhatia S, Robison LL, Oberlin O, et al.. Abstract: ... Systematic screening for breast cancer could be important in the health care of such women.. This is a service of:. Rheinische ... The risk of solid tumors, especially breast cancer, is high among women who were treated with radiation for childhood Hodgkins ... Patients who survive Hodgkins disease are at increased risk for second neoplasms. As survival times increase, solid tumors are ...

http://www.meb.uni-bonn.de/cgi-bin/mycite?ExtRef=MEDL/96172864/PMID/8592547

Comparative performance of multiview stereoscopic and mammographic display modalities for breast lesion detection. Webb, LJ; ... Browsing Masters Theses by Subject "Breast Neoplasms". 0-9. A. B. C. D. E. F. G. H. I. J. K. L. M. N. O. P. Q. R. S. T. U. V. W ...

https://dukespace.lib.duke.edu/dspace/handle/10161/2493/browse?type=subject&value=Breast+Neoplasms

intra-lobular (epithelial and stromal) inter-lobular breast lymphoma metastasis to breast Intralobular an... ... There are many types of breast neoplasms, which can be divided into the following broad oversimplified categories as a starting ... breast pathology *malignant lesions* breast cancer *breast adenocacrinoma *ductal breast carcinoma * ductal carcinoma in situ ( ... Breast within a breast sign in hamartomaBreast within a breast sign in hamartoma ...

https://radiopaedia.org/articles/breast-neoplasms

Keywords : intestinal obstruction; secondary; breast neoplasms; carcinoma; abdomen; acute. · abstract in Portuguese · text in ... Intestinal obstruction due to malign breast neoplasm and peritoneal carcinomatosis: a case report. J. Coloproctol. (Rio J.) [ ... A case of colonic obstruction due to carcinomatosis secondary to breast cancer is reported, emphasizing its diagnostic aspects ... Peritoneal carcinomatosis due to breast cancer is rare and gastrointestinal tract involvement is also unusual. Symptoms are ...

http://www.scielo.br/scielo.php?script=sci_abstract&pid=S2237-93632012000200016&lng=en&nrm=iso&tlng=en

Breast neoplasms Tier 1 H96. Breast neoplasms Tier 2 H96. Breast neoplasms Tier 3 H96. Breast neoplasms Tier 4 H96. Breast ... Breast neoplasms Tier 1 M96. Breast neoplasms Tier 2 M96. Breast neoplasms Tier 3 M96. Breast neoplasms Tier 4 M96. Breast ... Breast neoplasms Tier 1-4 H384 Predesigned 384-well panel for use with SYBR® Green ... Breast neoplasms Tier 1-4 M384 Predesigned 384-well panel for use with SYBR® Green ...

https://www.bio-rad.com/en-us/prime-pcr-assays/pathway/breast-neoplasms

... a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF Mod Pathol ... Excised fresh breast tissue for evaluation and/or treatment of a variety of breast lesions were sampled by FNA technique and ... In conclusion, FNA of breast tissue placed in PreservCyt is a potentially acceptable method of sample handling for evaluation ... Preliminary results from a spectrum of breast lesions suggest these patterns may have potential for ancillary testing for ...

https://pubmed.ncbi.nlm.nih.gov/15195106/?dopt=Abstract

Prevalence of risk factors for breast neoplasm in the city of Maringá, Paraná state, Brazil1 ... As for the family history of breast cancer, 2.3% (10) of the women reported that their mother has or had breast cancer. When ... This risk increases when the relative has breast cancer before the age of 50 years and in both breasts(15). ... with breast cancer(3). In both studies, a small number of women had some first-degree relatives with breast cancer, like in the ...

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692010000300009&lng=en&nrm=iso

Malignant neoplasm of prostate , Colorectal Cancer , Integration of Cancer Health Activities Into African American Churches ... breast, prostate, colorectal) delivered through trained and certified lay peer community health advisors in African American ...

https://www.centerwatch.com/clinical-trials/listings/178913/breast-cancer-integration-cancer-health-activities/?%E2%89%A5o_lat=38.9506%E2%89%A5o_lng=-76.9347&radius=10

Find doctors who treat Malignant Neoplasm of Female Breast near Washington, DC and accept WebMD.PhysicianDirectory.Types. ... Malignant Neoplasm of Female Breast. Female breast cancer (malignant neoplasm of female breast) occurs when abnormal cells ... Physicians Who Treat Malignant Neoplasm of Female Breast Who Accept CDPHP New York State of Health - Small Business Near ... These cancer cells can grow uncontrollably and spread outside the breast, usually through the lymph nodes or through the blood ...

https://doctor.webmd.com/find-a-doctor/condition/malignant-neoplasm-of-female-breast/district-of-columbia/washington/cdphp-new-york-state-of-health-small-business

Find doctors who treat Malignant Neoplasm of Female Breast near Washington, DC and accept WebMD.PhysicianDirectory.Types. ... Malignant Neoplasm of Female Breast. Female breast cancer (malignant neoplasm of female breast) occurs when abnormal cells ... Physicians Who Treat Malignant Neoplasm of Female Breast Who Accept Highmark Blue Cross Blue Shield Shared Cost 1500, a Multi- ... These cancer cells can grow uncontrollably and spread outside the breast, usually through the lymph nodes or through the blood ...

https://doctor.webmd.com/find-a-doctor/condition/malignant-neoplasm-of-female-breast/district-of-columbia/washington/highmark-blue-cross-blue-shield-shared-cost-1500-a-multi-state-plan

Higher-Than-Expected Incidence of Marrow Neoplasms After Adjuvant Therapy for Breast Cancer. By Matthew Stenger. May 25, 2015. ... Patients developing marrow neoplasms were significantly older than those who did not at the time of breast cancer diagnosis ( ... 1. Wolff AC, Blackford AL, Visvanathan K, et al: Risk of marrow neoplasms after adjuvant breast cancer therapy: The National ... The median time to diagnosis of marrow neoplasms after breast cancer diagnosis was 4.9 years. Overall survival after diagnosis ...

https://ascopost.com/issues/may-25-2015/higher-than-expected-incidence-of-marrow-neoplasms-after-adjuvant-therapy-for-breast-cancer/

Investigational Drugs with Clinical Trials for: Breast Neoplasms. ✉ Send this page by email. Email this page to a colleague ...

https://www.drugpatentwatch.com/p/drugs-in-development/indication/Breast+Neoplasms

C50.12 Malignant neoplasm of central portion of breast, male C50.121 Malignant neoplasm of central portion of right male breast ... C50.212 Malignant neoplasm of upper-inner quadrant of left female breast C50.219 Malignant neoplasm of upper-inner quadrant of ... C50.22 Malignant neoplasm of upper-inner quadrant of breast, male C50.221 Malignant neoplasm of upper-inner quadrant of right ... C50.222 Malignant neoplasm of upper-inner quadrant of left male breast C50.229 Malignant neoplasm of upper-inner quadrant of ...

https://www.icd10data.com/ICD10CM/Codes/C00-D49/C50-C50/C50-/C50.2

We report on and discuss a case of a female patient diagnosed with breast cancer in 1996, which was histopathologically ... Liver metastasis of a neuroendocrine neoplasm of unknown primary origin in a female patient with a history of breast cancer. ... "Liver metastasis of a neuroendocrine neoplasm of unknown primary origin in a female patient with a history of breast cancer". ... "Liver metastasis of a neuroendocrine neoplasm of unknown primary origin in a female patient with a history of breast cancer." ...

https://www.termedia.pl/Liver-metastasis-of-a-neuroendocrine-neoplasm-of-unknown-primary-origin-in-a-female-patient-with-a-history-of-breast-cancer,3,33211,0,1.html

Study aims were to evaluate the correlation between some risk factors and womens attendance to breast checkups, and to assess ... introduction and objective: In Poland, consulting is offered to women about risk factors of breast cancer, breast symptoms and ... Selected breast cancer risk factors and early detection of the neoplasm in women from Lublin region attending screening program ... The frequency of breast checkups (mammography, CBE and BSE) and occurrence of breast cancer risk factors in studied women were ...

http://www.aaem.pl/Selected-breast-cancer-risk-factors-and-early-detection-of-the-neoplasm-in-women,72199,0,2.html

Breast Cancer (Malignant neoplasm) under a microscope! (giantmicrobes.com)
Breast Cancer affects 1 in every 8 women, but early detection and proper screening can help ensure the best outcomes. (giantmicrobes.com)
Your purchase of our Breast Cancer cell is supporting NBCF's early detection, education and support services. (giantmicrobes.com)
FACTS: Breast cancer usually begins as a lump that can be seen in a mammogram or felt when the breast is examined. (giantmicrobes.com)
However, risk-factors that increase the probability of developing the disease include a family history of breast or ovarian cancer, increasing age, never having breastfed, never having given birth, long-term hormone replacement therapy, and smoking. (giantmicrobes.com)
Men can get breast cancer, too. (giantmicrobes.com)
Although breast cancer is extremely serious, most people (approximately 80%) who get it survive, particularly if treatment is initiated early in the course of the disease before it has spread from its original site. (giantmicrobes.com)
Breast cancer is a cellular disease caused by uncontrolled division of abnormal cells in breast tissue. (giantmicrobes.com)
What is breast cancer? (health.am)
Breast cancer is a disease in which malignant (cancer) cells form in the tissues of the breast. (health.am)
And when this process takes place in the breast, it's breast cancer. (health.am)
It is important to bear in mind that not all families with a pedigree suggestive of hereditary breast cancer are linked to BRCA1 or BRCA2. (health.am)
Fatty acids in the breast may be useful indicators of cancer in postmenopausal women, according to a new study published online in the journal Radiology. (health.am)
The results may help researchers determine the underlying mechanisms behind breast cancer development in some patients. (health.am)
Ductal, lobular, and medullary neoplasms are three of the main types of breast cancer . (knowcancer.com)
Doctors have established a genetic link in about 5% of breast cancer cases, so a family history of cancer can put one at risk. (knowcancer.com)
Women who got their periods before age 12, or enter menopause after 55, are more at risk of developing breast cancer. (knowcancer.com)
Breast cancer is more common in women who have their first full-term pregnancy after age 30. (knowcancer.com)
Women who have received radiation treatments to the chest, particularly when during breast development, are more likely to get breast cancer later on. (knowcancer.com)
Women who have been on hormone therapy or birth control pills for four or more years have a higher risk of breast cancer. (knowcancer.com)
Women with dense breasts are more likely to get breast cancer, although doctors aren't sure why. (knowcancer.com)
The first sign of breast cancer is usually a painless lump or thickening in the breast. (knowcancer.com)
Also searched for Breast Cancer and Breast carcinomas . (clinicaltrials.gov)
Phase I Open Label Trial to Assess Safety of BIBW 2992 (Afatinib) in Combination With Herceptin® in Patients With HER2-positive Advanced Breast Cancer. (drugbank.ca)
A recessive variant of XRCC4 predisposes to non- BRCA1/2 breast cancer in chinese women and impairs the DNA damage response via dysregulated nuclear localization. (duke.edu)
PURPOSE: To define the biology driving the aggressive nature of breast cancer arising in young women. (duke.edu)
An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. (duke.edu)
Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms. (duke.edu)
The observed bimodal patterns of breast cancer incidence in the U.S. suggested that breast cancer may be viewed as more than one biological entity. (duke.edu)
Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug Resistance in Breast Cancer. (duke.edu)
Effect of socioeconomic status as measured by education level on survival in breast cancer clinical trials. (duke.edu)
ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer. (curehunter.com)
Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. (curehunter.com)
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. (curehunter.com)
Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP/DOPE liposomes. (curehunter.com)
Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study. (curehunter.com)
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. (curehunter.com)
Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes. (curehunter.com)
Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis. (curehunter.com)
A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy. (drugbank.ca)
Breast cancer is the second leading cause of cancer death in women (following lung cancer lung cancer, cancer that originates in the tissues of the lungs. (thefreedictionary.com)
Although the vast majority of the cases occur in women, some men also get breast cancer. (thefreedictionary.com)
Even allowing for improvements in detection (i.e., the introduction of routine mammography), there has been a long-term gradual increase in the incidence of breast cancer since the early 1970s, but because of the more effective treatment afforded by such early detection, overall mortality began to decrease by the mid-1990s. (thefreedictionary.com)
Epidemiological study has identified certain risk factors that increase the possibility that a woman will get breast cancer, although not all women with breast cancer have these traits, and many women with all of these traits do not develop the disease. (thefreedictionary.com)
and a history of breast cancer or benign proliferative breast disease. (thefreedictionary.com)
a coincident drop in the incidence of breast cancer tumors, especially estrogen-positive tumors, which apparently could not be accounted for by other causes, strongly suggested a link between the two. (thefreedictionary.com)
About 5% of women with breast cancer have an inherited susceptibility to the disease, and most of these women have an inherited mutation in one of two genes. (thefreedictionary.com)
In 1994 it was discovered that women who inherit a mutated BRCA1 gene have an almost 85% chance of developing breast cancer and an increased chance of developing uterine cancer. (thefreedictionary.com)
The defective gene can be inherited from either parent, but appears to cause breast cancer only in women. (thefreedictionary.com)
Young women who get breast cancer often come from families that carry a BRCA1 mutation. (thefreedictionary.com)
Response to preoperative endocrine therapy in breast cancer patients can alter surgical and chemotherapy options. (curehunter.com)
GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. (curehunter.com)
Spotlight on neoadjuvant therapy for breast cancer. (curehunter.com)
Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). (curehunter.com)
Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. (curehunter.com)
Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer. (curehunter.com)
2000 cGy) of radiation (relative risk, 5.9) were associated with significantly increased risk of breast cancer. (uni-bonn.de)
The risk of solid tumors, especially breast cancer, is high among women who were treated with radiation for childhood Hodgkin's disease. (uni-bonn.de)
Systematic screening for breast cancer could be important in the health care of such women. (uni-bonn.de)
Solitary peripheral papilloma of the breast: a radiologic-pathologic correlation of a benign lesion that may mimic breast cancer on mammography. (radiopaedia.org)
Peritoneal carcinomatosis due to breast cancer is rare and gastrointestinal tract involvement is also unusual. (scielo.br)
Investigation of carcinomatosis origin is mandatory as breast cancer carcinomatosis can relieve partially or totally with chemo and hormonal therapy. (scielo.br)
A case of colonic obstruction due to carcinomatosis secondary to breast cancer is reported, emphasizing its diagnostic aspects and treatment. (scielo.br)
The aim of this study was to identify the prevalence of the risk factors for breast cancer among women between 40 and 69 years old in the city of Maringá, Paraná State, Brazil. (scielo.br)
Of all cancer types, breast tumors stand out among women, as observed by the frightening statistics. (scielo.br)
Estimates for 2008 in Brazil, valid for 2009 as well, indicate 466,730 new cases of cancer and one of the most incident types among women is breast cancer, with an estimated number of 49,400 new cases (50.71/100,000 women). (scielo.br)
Breast tumors are the most frequent type of cancer among women in the South of Brazil, totaling an estimated risk of 67/100,000 women. (scielo.br)
In Paraná, 2970 new cases of breast cancer (56.7/100,000 women) occurred in 2006. (scielo.br)
Until date, breast cancer cannot be avoided, but some risk factors of the disease have already been discovered, which can facilitate early detection and contribute to cancer screening (3) . (scielo.br)
The most discussed risk factors are the woman s age and family history, that is, having a first-degree relative with breast cancer (4) . (scielo.br)
Incidence levels of breast cancer increase rapidly until the age of 50, after which the increase continues at a slower pace (1) . (scielo.br)
In scientific terms, there are no specific strategies that permit primary breast cancer prevention, although its incidence can be decreased through health promotion actions, emphasizing attention with risk factors, including obesity and smoking (5) . (scielo.br)
In view of this problem, this research intended to identify the prevalence of risk factors for breast cancer in women between 40 and 69 years, in Maringá, PR. (scielo.br)
This age range was chosen due to the greater prevalence of illness and death by breast cancer in the age range between 40 and 69 years (5) . (scielo.br)
Project HEAL is a series of three cancer early detection workshops (breast, prostate, colorectal) delivered through trained and certified lay peer community health advisors in African American churches. (centerwatch.com)
Female breast cancer (malignant neoplasm of female breast) occurs when abnormal cells develop in the breast. (webmd.com)
These cancer cells can grow uncontrollably and spread outside the breast, usually through the lymph nodes or through the blood stream. (webmd.com)
In a study reported in the Journal of Clinical Oncology , Antonio C. Wolff, MD , of Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, and colleagues found a low but higher-than-expected incidence of marrow neoplasms in patients receiving adjuvant radiation therapy or chemotherapy for breast cancer. (ascopost.com)
The study used the National Comprehensive Cancer Network Breast Cancer Outcomes Database to evaluate the frequency of marrow neoplasms among 20,063 patients with stage I to III breast cancer treated at U.S. academic centers between 1998 and 2007. (ascopost.com)
Patients developing marrow neoplasms were significantly older than those who did not at the time of breast cancer diagnosis (median = 59.1 vs 53.9 years, P = .03). (ascopost.com)
The median time to diagnosis of marrow neoplasms after breast cancer diagnosis was 4.9 years. (ascopost.com)
As noted by the authors, a 2003 report from the National Surgical Adjuvant Breast and Bowel Project indicated an 8-year cumulative incidence of MDS or AML of 0.27% among breast cancer patients receiving doxorubicin and cyclophosphamide. (ascopost.com)
Family history of cancer and marrow cytogenetics were available for 41 of the patients with marrow neoplasms. (ascopost.com)
19 (59%) of the 32 patients with a family history of cancer had at least one first- or second-degree relative with breast or ovarian cancer. (ascopost.com)
BackgroundSeveral accomplishments have been achieved in triple-negative breast cancer (TNBC) research over the last year. (semanticscholar.org)
Recent therapeutic trends and promising targets in triple negative breast cancer. (semanticscholar.org)
Targeting the PI3-kinase pathway in triple negative breast cancer. (semanticscholar.org)
Triple negative breast cancer (TNBC) is characterised by poor outcomes and a historical lack of targeted therapies. (semanticscholar.org)
BACKGROUND Standard first-line treatment of metastatic triple-negative breast cancer (mTNBC) is chemotherapy. (semanticscholar.org)
Abstract Breast cancer is the most prevalent cancer among women worldwide. (semanticscholar.org)
Struk-Panfill M, Błaut K, Pęksa R, Kmieć P, Sworczak K. Liver metastasis of a neuroendocrine neoplasm of unknown primary origin in a female patient with a history of breast cancer. (termedia.pl)
We report on and discuss a case of a female patient diagnosed with breast cancer in 1996, which was histopathologically assessed as an invasive ductal carcinoma. (termedia.pl)
Due to unknown primary site of the metastasis and given the patient's history of breast cancer, it was suspected that the breast cancer was in fact a neuroendocrine tumour. (termedia.pl)
In Poland, consulting is offered to women about risk factors of breast cancer, breast symptoms and early cancer detection. (aaem.pl)
Study aims were to evaluate the correlation between some risk factors and women's attendance to breast checkups, and to assess links between risk factors and detection of early breast cancer. (aaem.pl)
The study involved 8014 women aged 50-69 years, participating in breast cancer screening program. (aaem.pl)
The frequency of breast checkups (mammography, CBE and BSE) and occurrence of breast cancer risk factors in studied women were evaluated as well as clinical stage of detected tumors. (aaem.pl)
Odds ratios were used to compare relative odds of breast cancer with exposure to risk factors. (aaem.pl)
There were no significant links between most risk factors and odds of early stages of breast cancer. (aaem.pl)
Women should have preventive checkups irrespective of their breast cancer risk factors. (aaem.pl)
Estrogen carcinogenesis in breast cancer. (aaem.pl)
Beiki O, Hall P, Ekbom A, Moradi T. Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study. (aaem.pl)
Gareth D, Evans R, Howell A. Breast cancer risk-assessment models. (aaem.pl)
Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models. (aaem.pl)
Active Smoking and Breast Cancer Risk: Original Cohort Data and Meta-Analysis. (aaem.pl)
Pięta B, Chmaj-Wierzchowska K, Opala T. Life style and risk of development of breast and ovarian cancer. (aaem.pl)
Meads C, Ahmed I, Riley RD. A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. (aaem.pl)
Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. (aaem.pl)
to understand the meaning of work activities for young women with breast cancer . (bvsalud.org)
interviewed from the guiding question how is it for you to be young with breast cancer , in relation to work ? (bvsalud.org)
Four patients had a known history of breast cancer (remote in 3 and concurrent in 1), but the metastases (3 liver, 1 lung) labeled for chromogranin and/or synaptophysin, prompting misdiagnosis as neuroendocrine neoplasm. (elsevier.com)
an occult concurrent primary breast cancer (PBC) was subsequently identified as the source. (elsevier.com)
In conclusion, although neuroendocrine differentiation is uncommon in breast cancer and does not commonly increase in metastases, MBC with neuroendocrine differentiation should be considered in patients with visceral neuroendocrine neoplasms of unknown primary site. (elsevier.com)
Cervical cancer and breast cancer are leading causes of cancer-related morbidity and mortality in Costa Rica. (paho.org)
Tumors or cancer of the human BREAST. (uchicago.edu)
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. (uchicago.edu)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. (uchicago.edu)
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells. (uchicago.edu)
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. (uchicago.edu)
the COVID-19 pandemic breast cancer consortium. (uchicago.edu)
In addition, these results suggest that the initiating oncogenic events determine the morphologic features associated with cancer progression because EMT is observed only in certain types of neoplasm. (biomedcentral.com)
Transgenic mouse models of mammary cancer have added considerably to our knowledge of human breast tumorigenesis. (biomedcentral.com)
12 A breast cancer that arises from myoepithelial cells, which are a normal constituent of the salivary acini and ducts and are found between the epithelial cells and the basement membrane. (malacards.org)
The incidence of DCIS has increased with the development of mammography screening for breast cancer. (wikidot.com)
This article provides an overview for radiologists, with a focus on breast cancer . (pacs.de)
For a summary article for medical students and non-radiologists, see breast cancer (summary) . (pacs.de)
Breast cancer is the most common nonskin malignancy in women. (pacs.de)
Enhanced anti-tumor and anti-metastasis therapy for triple negative breast cancer by CD44 receptor-targeted hybrid self-delivery micelles. (mazenz.com)
Related Articles Enhanced anti-tumor and anti-metastasis therapy for triple negative breast cancer by CD44 receptor-targeted hybrid self-delivery micelles. (mazenz.com)
Dendrimer mediated targeting of siRNA against polo-like kinase for the treatment of triple negative breast cancer. (mazenz.com)
Related Articles Dendrimer mediated targeting of siRNA against polo-like kinase for the treatment of triple negative breast cancer. (mazenz.com)
The p160 steroid receptor coactivators (SRCs) SRC-1, SRC-2 [nuclear receptor coactivator (NCOA)2], and SRC-3 [amplified in breast cancer 1 (AIB1)/NCOA3] are key pleiotropic "master regulators" of transcription factor activity necessary for cancer cell proliferation, survival, metabolism, and metastasis. (usda.gov)
Regional differences in surgical management of breast cancer. (doctorasyou.com)
Global breast cancer mortality statistics. (doctorasyou.com)
Using a population-based cancer reporting system to evaluate a breast cancer detection and awareness program. (doctorasyou.com)
Local excision and primary radiation therapy for early breast cancer. (doctorasyou.com)
Response: the case for the two-step biopsy procedure for breast cancer. (doctorasyou.com)
American Society of Clinical Oncology clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. (blogspot.com)
The role of IMRT in breast cancer. (blogspot.com)
Breast cancer screening clinical practice guideline. (blogspot.com)
Adjuvant ovarian ablation in the treatment of premenopausal women with early stage invasive breast cancer. (blogspot.com)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. (blogspot.com)
Zoledronic acid as adjuvant therapy in combination with adjuvant endocrine therapy for premenopausal women with early-stage hormone receptor positive breast cancer. (blogspot.com)
1) Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. (blogspot.com)
The prophylactic use of filgrastim in patients with breast cancer. (blogspot.com)
The continued use of trastuzumab beyond disease progression in patients with metastatic breast cancer. (blogspot.com)
The use of bevacizumab in metastatic breast cancer. (blogspot.com)
UICC multidisciplinary project on breast cancer : reports of the four meetings held at Leeds Castle (Kent, UK in 1980, 1981, and 1982. (who.int)
Breast cancer : epidemiology, endocrinology, biochemistry and pathobiology / Helmuth Vorherr. (who.int)
Primary management of breast cancer : alternatives to mastectomy / edited by Jeffrey S. Tobias and Michael J. Peckham. (who.int)
Prevention of breast cancer / Ian S. Fentiman. (who.int)
Breast and gynecologic cancer epidemiology / authors, Jennifer L. Kelsey, Nancy G. Hildreth. (who.int)
Oral contraceptives & breast cancer / Committee on the Relationship between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention. (who.int)
Patient no more : the politics of breast cancer / Sharon Batt. (who.int)
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. (blogspot.com)
ACR Appropriateness Criteria® stage I breast cancer: initial workup and surveillance for local recurrence and distant metastases in asymptomatic women. (blogspot.com)
Ki-67 and IHC4) in early-stage breast cancer. (blogspot.com)
Medications for risk reduction of primary breast cancer in women: U.S. Preventive Services Task Force recommendation statement. (blogspot.com)
Treatment of primary breast cancer. (blogspot.com)
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. (blogspot.com)
Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy. (blogspot.com)
Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. (blogspot.com)
NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer. (blogspot.com)
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. (blogspot.com)
International Copenhagen Symposium on Detection of Breast Cancer (3rd : 1985). (phsa.ca)
The incidence of multiple primary malignant neoplasms increases with age, reflecting an increase in overall cancer risk in older patients. (biomedcentral.com)
He did have a family history of malignancy though, as his father had developed rectal cancer and his sister had a kidney neoplasm. (biomedcentral.com)
Breast cancer is an uncontrollable growth of abnormal cells in different areas of the chest. (ac.ir)
Research about the causes of breast cancer is crucial. (ac.ir)
Researchers have submitted further evidences about the relationship between some of the chemical used in home environment and breast cancer. (ac.ir)
Although there are not conclusive evidences to prove the role of certain chemicals for increasing the risk of breast cancer, there are many reasons for increasing concerns in this area that will be discussed in details. (ac.ir)
Specifically, those women who have a family history of this disease and those whose lifestyle's are in a way that makes them more at risk of breast cancer, the examinations and tests should be done on a regular basis in order to cure this diseases at the early stages. (ac.ir)
But thanks to the prevalence of medical tourism, patients with breast neoplasms can now undergo cancer treatment in Southeast Asia at 50% to 75% less than its usual cost. (docdoc.com)
Mainly taken from risk factors for breast cancer, risk factors can be described in terms of, for example: Relative risk, such as "A woman is more than 100 times more likely to develop breast cancer in her 60s than in her 20s. (wikipedia.org)
Fraction of incidences occurring in the group having the property of or being exposed to the risk factor, such as "99% of breast cancer cases are diagnosed in women. (wikipedia.org)
Recent research has shown that most of the excess risk of death following breast and colorectal cancer in England compared with Norway and Sweden occurs in older age groups during the first year, and especially in the first month of follow-up. (nature.com)
These results suggest that early mortality after a diagnosis of breast or colorectal cancer may be partly due to comorbidity and lifestyle factors, as well as due to more advanced disease. (nature.com)
The aim of this study was to examine the characteristics of patients with breast or colorectal cancer who die within 30 days of diagnosis, using health service data collected routinely and, using proxy indicators, to explore the influence of socioeconomic deprivation, co-morbidity, and lifestyle on outcome. (nature.com)
Anonymised records relating to patients diagnosed with breast cancer (ICD-10 C50) or colorectal cancer (C18-C20) during the period 2003-2007 were extracted from the Scottish Cancer Registry (SCR). (nature.com)
Only the first breast or colorectal cancer arising in an individual was included in the analysis. (nature.com)
Unlike breast cancer, colon cancer is thought to be more homogeneous with a single dominant pathway and histological presentation during tumor progression [ 11 ]. (biomedcentral.com)
Soft-Tissue Sarcomas, Breast Cancer, and Other NeoplasmsA Familial Syndrome? (annals.org)
The increased familial susceptibility to cancer was manifested not only by the large number of members affected but by a seeming excess of multiple primary neoplasms. (annals.org)
Should This Woman With Dense Breasts Receive Supplemental Breast Cancer Screening? (annals.org)
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. (bioseek.eu)
FRIDAY, Jan. 12, 2018 (HealthDay News) -- Lynparza (olaparib) has been approved by the U.S. Food and Drug Administration to treat spreading breast cancer caused by a BRCA gene mutation. (hon.ch)
This class of drugs has been used to treat advanced, BRCA-mutated ovarian cancer and has now shown efficacy in treating certain types of BRCA-mutated breast cancer," said Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence. (hon.ch)
More than 250,000 women in the United States are projected to be diagnosed with breast cancer this year, and more than 40,000 will die from it, according to estimates from the U.S. National Cancer Institute. (hon.ch)
About 5 to 10 percent of people with breast cancer have a BRCA mutation, the FDA said. (hon.ch)
Lynparza was evaluated to treat breast cancer in clinical studies involving 302 people. (hon.ch)
Male breast cancer is a rare entity, with an approximate rate of 1.1 / 100 000 in the US, with an average age of 67 years. (nih.gov)
53 -year-old male diagnosed with right breast cancer, infiltrating ductal adenocarcinoma type, clinical stage IIB, breast cancer on 2 immediate family history, mutations of the BRCA1 gene and positive hormone receptors and Her2/Neu. (nih.gov)
Breast cancer in male patient has a worse prognosis than female patients, due to lower amount of tissue in breast exposed to an earlier chest spread and a different biological behavior, also a higher risk of prostate and pancreatic cancer is associated. (nih.gov)
Studies of adequate methodological quality are scarce, so that decisions are based on guidelines for breast cancer in women. (nih.gov)
Breast cancer accounts for one-third of cancer diagnoses and 15% of cancer deaths in U.S. women. (wiley.com)
Over one-half of the 300,000 breast cancer deaths worldwide in 1990 (the latest year with such data) occurred in developed countries, but annual mortality rates ranged from 27/100,000 women in northern Europe to 4/100,000 women in Asia. (wiley.com)
FRIDAY, Sept. 29, 2017 (HealthDay News) -- Verzenio (abemaciclib) has been approved by the U.S. Food and Drug Administration to treat women with certain advanced forms of breast cancer, the most common cancer in the United States. (hon.ch)
The drug is approved for hormone receptor-positive and HER2-negative forms of advanced or spreading breast cancer that have been treated with a therapy that changes a person's hormones (endocrine therapy). (hon.ch)
Verzenio provides a new targeted treatment option for certain patients with breast cancer who are not responding to treatment, and unlike [similar drugs], it can be given as a standalone treatment to patients who were previously treated with endocrine therapy and chemotherapy," said Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence. (hon.ch)
The drug was evaluated in clinical studies involving almost 700 people whose breast cancer had progressed after treatment with endocrine therapy. (hon.ch)
Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy. (nih.gov)
Breast cancer in young women has been shown to have an aggressive behavior and worse prognosis. (nih.gov)
Abstract Two hundred and thirty-five consecutive patients presenting to a single center with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) after breast cancer treatment were compared with matched patients with de novo AML or MDS. (elsevier.com)
Having therapy-related disease is not an independent risk factor in patients with myeloid neoplasms and with a history of breast cancer. (elsevier.com)
Additionally, this study will characterize the pharmacokinetics parameters in Chinese postmenopausal women with advanced breast cancer. (clinicaltrials.gov)
Estrogen receptor (ER) and / or progesterone receptor (PR) positive breast cancer confirmed by pathology. (clinicaltrials.gov)
Once received a non-steroidal aromatase inhibitor (letrozole / anastrozole) treatment, the disease recurrence or progression of breast cancer currently. (clinicaltrials.gov)
This multicenter, single-arm observational study will evaluate the clinical benefits of Avastin (bevacizumab) in combination with paclitaxel in first-line treatment in patients with metastatic breast cancer. (clinicaltrials.gov)
Patients with metastatic breast cancer who have started Avastin treatment within 6 months prior to study start will also be eligible. (clinicaltrials.gov)
Number of participants at each Metastatic breast cancer stage 0, I, II, III or IV, at the point of diagnosis is reported. (clinicaltrials.gov)
Breast cancer-a diagnosis that would daunt any woman. (who.int)
This very personal and uplifting account of one Egyptian woman's experience with breast cancer offers hope to all. (who.int)
The widespread use of triclosan and its detection in human breast milk, urine, and serum have raised concerns regarding its association with various health outcomes, including cancer development [ 4 ]. (mdpi.com)
Breast cancer remains a common and frequently fatal disease, the most commonly diagnosed cancer in women and the second leading cause of cancer death in the Eastern Mediterranean Region. (who.int)
Although breast cancer is much more common in women, men can get it too. (medlineplus.gov)
Breast lumps usually aren't cancer. (medlineplus.gov)
However, most men with breast cancer have lumps. (medlineplus.gov)
Risk factors for male breast cancer include exposure to radiation, a family history of breast cancer, and having high estrogen levels, which can happen with diseases like cirrhosis or Klinefelter's syndrome . (medlineplus.gov)
Treatment for male breast cancer is usually a mastectomy , which is surgery to remove the breast. (medlineplus.gov)
Can Breast Cancer in Men Be Found Early? (medlineplus.gov)
How Is Breast Cancer in Men Diagnosed? (medlineplus.gov)
We report our experience with adverse reactions to isosulfan blue dye during SLN mapping in breast cancer. (nih.gov)
We report the largest single-institution review of adverse reactions to injection of isosulfan blue dye during sentinel lymph node mapping in breast cancer. (nih.gov)
The author combines a complete, superbly illustrated atlas of imaging findings with a comprehensive text that covers all imaging modalities and addresses all aspects of breast imaging-including breast anatomy, histology, physiology, pathology, breast cancer staging, and preoperative localization of occult lesions. (powells.com)

DelveInsight's " Triple Negative Breast Neoplasms - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Triple Negative Breast Neoplasms , historical and forecasted epidemiology as well as the Triple Negative Breast Neoplasms market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. (delveinsight.com)
The Triple Negative Breast Neoplasms market report provides current treatment practices, emerging drugs, Triple Negative Breast Neoplasms market share of the individual therapies, current and forecasted Triple Negative Breast Neoplasms market Size from 2017 to 2030 segmented by seven major markets. (delveinsight.com)
The Report also covers current Triple Negative Breast Neoplasms treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. (delveinsight.com)
The DelveInsight Triple Negative Breast Neoplasms market report gives a thorough understanding of the Triple Negative Breast Neoplasms by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment. (delveinsight.com)
It covers the details of conventional and current medical therapies available in the Triple Negative Breast Neoplasms market for the treatment of the condition. (delveinsight.com)
It also provides Triple Negative Breast Neoplasms treatment algorithms and guidelines in the United States, Europe, and Japan. (delveinsight.com)
The Triple Negative Breast Neoplasms epidemiology division provide insights about historical and current Triple Negative Breast Neoplasms patient pool and forecasted trend for every seven major countries. (delveinsight.com)
The disease epidemiology covered in the report provides historical as well as forecasted Triple Negative Breast Neoplasms epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030. (delveinsight.com)
The epidemiology segment also provides the Triple Negative Breast Neoplasms epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. (delveinsight.com)
Drug chapter segment of the Triple Negative Breast Neoplasms report encloses the detailed analysis of Triple Negative Breast Neoplasms marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. (delveinsight.com)
It also helps to understand the Triple Negative Breast Neoplasms clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases. (delveinsight.com)
The report provides the details of the marketed product available for Triple Negative Breast Neoplasms treatment. (delveinsight.com)
The report provides the details of the emerging therapies under the late and mid-stage of development for Triple Negative Breast Neoplasms treatment. (delveinsight.com)
The Triple Negative Breast Neoplasms market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Triple Negative Breast Neoplasms market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. (delveinsight.com)

The preoperative clinical workup of an apparently healthy patient with a breast mass can be cursory and is unlikely to exclude a metastasis from a clinically inapparent (that is, "occult") nonmammary malignant neoplasm (NMMN). (basicmedicalkey.com)
Thus, when faced with a mammary neoplasm that has unusual clinical, radiologic, or histologic features, it is important to consider metastasis in the differential diagnosis. (basicmedicalkey.com)
In approximately one-third of the cases, the metastasis in the breast is the first presentation of the NMMN. (basicmedicalkey.com)
Metastasis from the contralateral breast is a diagnostic consideration when there is bilateral involvement (or history thereof), the histologic appearances of the tumors in the breasts are similar, and there is no evidence of in situ carcinoma in the contralateral breast. (basicmedicalkey.com)

Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified ( C25.9 ). (icd10data.com)
Metastases from NMMN are rare and account for less than 1% of all mammary malignant neoplasms in clinical series, and up to 5% of autopsies of patients who die as a result of NMMN ( 1 ). (basicmedicalkey.com)

Inflammatory Breast Neoplasms research, articles, guidelines & medical evidence database search. (doctorasyou.com)
Access the latest scientific research and medical evidence related to Inflammatory Breast Neoplasms treatment, diagnosis and symptoms, quickly and easily with doctorAsyou. (doctorasyou.com)

Breast cancers can arise in the lobes or lobules (lobular carcinoma) or in the ducts (ductal carcinoma) of the breast. (thefreedictionary.com)
Here, we report the case of a 57-year-old man who was referred to our institution with synchronous squamous cell carcinoma of the skin on the forehead, infiltrating ductal carcinoma of the breast, and transitional cell carcinoma of the urinary bladder. (biomedcentral.com)
In this report, we describe the case of a patient who developed synchronous primary transitional cell carcinoma (TCC) of the urinary bladder, squamous cell carcinoma (SCC) of the skin on the forehead, and infiltrating ductal breast carcinoma. (biomedcentral.com)

12 A breast benign neoplasm that forms from cells that release hormones into the blood in response to a signal from the nervous system. (malacards.org)

Breast Neuroendocrine Neoplasm, also known as neuroendocrine tumor of the breast , is related to neuroendocrine tumor and peritoneal serous adenocarcinoma . (malacards.org)
An important gene associated with Breast Neuroendocrine Neoplasm is SYP (Synaptophysin). (malacards.org)

This system uses sound waves to create 3D images of the breast, showing a better picture of the tumor. (knowcancer.com)
Primary desmoid tumor (extraabdominal fibromatosis) of the breast. (radiopaedia.org)
Well-differentiated neuroendocrine tumor of the breast with extensive lymphatic and vascular infiltration. (malacards.org)
Well-differentiated neuroendocrine tumor of the breast with recurrence due to needle tract seeding. (malacards.org)
Primary neuroendocrine tumor of the breast. (malacards.org)
Expression patterns for terminal differentiation markers were used to characterize tumor types and to study tumor progression in transgenic mouse models of mammary neoplasia (mice overexpressing Neu ( Erbb2 ), Hras , Myc , Notch4 , SV40-TAg , Tgfa , and Wnt1 ), in spontaneous mammary carcinomas, and in mammary neoplasms associated with infection by the mouse mammary tumor virus (MMTV). (biomedcentral.com)
and third, 'carcinomas with epithelial to mesenchymal transition (EMT)' are a characteristic feature of tumor progression in Hras- , Myc- , and SV40-TAg- induced mammary neoplasms and PL/J and SJL/J mouse strains, and display de novo expression of myoepithelial and mesenchymal cell markers. (biomedcentral.com)
However, because of overlapping of cytologic features, surgical excision should be warranted in all cases of papillary lesions of the breast to further characterize the tumor. (jpatholtm.org)
A urogenital neoplasm is a tumor of the urogenital system. (icd.codes)
Tumor heterogeneity is defined as the simultaneous presence of multiple clonal subpopulations of tumor cells within a single neoplasm [ 1 ]. (biomedcentral.com)
40 years regarding the achievement of a pCR (defined as no invasive residual tumor in the breast or lymph nodes). (nih.gov)

The Late Effects Study Group followed a cohort of 1380 children with Hodgkin's disease to determine the incidence of second neoplasms and the risk factors associated with them. (uni-bonn.de)
The cumulative incidence of marrow neoplasms exhibited a continuous increase, with a cumulative incidence of 0.24% after 5 years and 0.48% after 10 years. (ascopost.com)

Postmenopausal women with histologically confirmed, measurable locally advanced disease or metastatic breast. (knowcancer.com)
A series of metastatic breast carcinoma (MBC) mimicking visceral well-differentiated neuroendocrine neoplasms has not previously been reported. (elsevier.com)

The generally accepted definition of MPC was introduced by Worren and Gates, who stated that each neoplasm must represent a distinct malignancy, and that a metastatic origin must be excluded [ 6 ]. (biomedcentral.com)

The Table of Neoplasms should be used to identify the correct topography code. (icd10data.com)

Women using HRT and women after breast biopsy were significantly more likely to attend breast checkups. (aaem.pl)
Dedicated evaluation of the breast involves multiple imaging modalities to detect and localize lesions for biopsy. (pacs.de)
Vascular lesions (VLs) of the breast present a diagnostic challenge on breast core biopsy (BCBx). (elsevier.com)

Each of these 7 had myeloid neoplasms, with 3 having abnormalities associated with MDS. (ascopost.com)

Hematopoietic and lymphoid neoplasms involving the breast are sometimes listed under the rubric of breast "metastases," but they are best regarded as either primary breast neoplasms or as a manifestation of a systemic condition, depending upon the extent of organ involvement. (basicmedicalkey.com)
If hematopoietic and lymphoid neoplasms are excluded, the most common NMMNs that secondarily involve the breast include carcinomas of the lung, ovary, stomach, kidney, and cutaneous melanoma. (basicmedicalkey.com)

Although many of the epithelial lesions/changes listed below are neoplastic, they are best thought of as neoplasms at increased risk and along a continuum with normal breast at one end and invasive carcinoma at the other. (radiopaedia.org)

Over the past 20 years, immunohistochemistry has added a molecular dimension to the categorization of mammary neoplasms: altered expression of oncogenes, oncosuppressor genes, hormone receptors, and cytoskeletal proteins have been identified as useful indicators of disease outcome. (biomedcentral.com)

A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. (icd10data.com)
Noncytokeratin expressing primary melanoma of the breast is neurogenic in origin and cytokeratin-negative. (basicmedicalkey.com)
Nonetheless, primary melanocytic lesions of the breast are exceedingly less common than metastatic melanocytic neoplasms. (basicmedicalkey.com)
Among the metastatic carcinomas in the breast that are most likely to be mistaken for a breast primary are those arising in the lung, ovary, mullerian system, and bowel. (basicmedicalkey.com)
To the best of our knowledge, this is the first reported case in literature of this combination of primary neoplasms. (biomedcentral.com)

Male Breast Neoplasms anonymous support group with information on diagnosis, treatment, symptoms, along with personal stories and experiences with Male Breast Neoplasms. (experienceproject.com)
Breast Myoepithelial Neoplasm, also known as malignant breast myoepithelioma , is related to breast adenomyoepithelioma and breast myoepitheliosis , and has symptoms including pain An important gene associated with Breast Myoepithelial Neoplasm is HSD11B2 (Hydroxysteroid 11-Beta Dehydrogenase 2), and among its related pathways/superpathways are Keratinization and Cytoskeleton remodeling Neurofilaments . (malacards.org)

paciente masculino de 53 años de edad, con diagnóstico de cáncer de mama derecha, tipo adenocarcinoma canalicular infiltrante, estadio clínico IIB, con antecedentes de cáncer de mama en 2 familiares directos, mutaciones del gen BRCA1 y positivo tanto a receptores hormonales como para el gen Her2/Neu. (nih.gov)

Metastases have been described in the ipsilateral axillary lymph nodes in a substantial proportion of patients with metastases in the breast ( 2 ). (basicmedicalkey.com)

Breast Neoplasms complications. (illinois.edu)
The concept Breast Neoplasms -- complications -- popular works represents the subject, aboutness, idea or notion of resources found in College of Physicians of Philadelphia . (collegeofphysicians.org)

This may be because the breasts are exposed to estrogen for a longer period. (knowcancer.com)

Fortunately, the majority of breast lumps are non-malignant cysts or fibrous tissue. (giantmicrobes.com)
Breasts are considered "dense" when there is a high ratio of tissue to fat. (knowcancer.com)
Excised fresh breast tissue for evaluation and/or treatment of a variety of breast lesions were sampled by FNA technique and placed into PreservCyt. (nih.gov)
In conclusion, FNA of breast tissue placed in PreservCyt is a potentially acceptable method of sample handling for evaluation by the SELDI-TOF methodology for establishment of reproducible protein patterns. (nih.gov)
Radiologic techniques such as MRI (magnetic resonance imaging) and FDG-PET/CT (fluorodeoxyglucose-positron emission tomography-computed tomography) have also detected metastases in the breast from carcinoma of the thyroid ( 7 ), ovary ( 8 ), and soft tissue liposarcoma ( 9 ). (basicmedicalkey.com)

Medullary carcinoma of the breast: mammographic and US appearance. (radiopaedia.org)
carcinoma of the breast occurred in three mothers under 30 years of age. (annals.org)

After 109,560 person-years of follow-up, the overall rate of marrow neoplasms in the entire cohort was 0.46 per 1,000 person-years, with rates per 1,000 person-years of 0.16 in those receiving surgery alone, 0.43 in those receiving adjuvant radiation alone, 0.46 in those receiving adjuvant chemotherapy alone, and 0.54 in those receiving both adjuvant treatments. (ascopost.com)

C79.81 is a billable code used to specify a medical diagnosis of secondary malignant neoplasm of breast. (icdlist.com)

Lobular carcinoma often affects both breasts. (thefreedictionary.com)

Anatomy9

Organisms1

Diseases104

Chemicals and Drugs28

Analytical, Diagnostic and Therapeutic Techniques and Equipment53

Psychiatry and Psychology2

Phenomena and Processes21

Disciplines and Occupations1

Technology, Industry, Agriculture1

Information Science3

Named Groups1

Health Care22

Diphtheria toxin effects on human cells in tissue culture. (1/42895)

The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. (2/42895)

The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. (3/42895)

The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture. (4/42895)

Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530. (5/42895)

Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. (6/42895)

Increased expression of fibroblast growth factor 8 in human breast cancer. (7/42895)

Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells. (8/42895)

Breast Neoplasms

Inflammatory Breast Neoplasms

Triple Negative Breast Neoplasms

Breast

Breast Neoplasms, Male

Carcinoma, Ductal, Breast

Breast Diseases

Breast Feeding

Neoplasms

Pancreatic Neoplasms

Receptors, Estrogen

Mammography

Neoplasms, Cystic, Mucinous, and Serous

Cell Line, Tumor

Fibrocystic Breast Disease

Tumor Markers, Biological

Neoplasm Invasiveness

Immunohistochemistry

Neoplasms, Multiple Primary

Receptor, erbB-2

Neoplasm Staging

Breast Implants

Receptors, Progesterone

Gene Expression Regulation, Neoplastic

Neoplasms, Second Primary

Breast Self-Examination

Neoplasm Proteins

Neoplasm Metastasis

Skin Neoplasms

Prognosis

Tamoxifen

DNA, Neoplasm

Carcinoma, Intraductal, Noninfiltrating

Ovarian Neoplasms

Carcinoma

Mastectomy

Adenocarcinoma, Mucinous

Lung Neoplasms

Kidney Neoplasms

Carcinoma, Lobular

Risk Factors

Neoplasm Recurrence, Local

Bone Neoplasms

Lymphatic Metastasis

Ultrasonography, Mammary

Thyroid Neoplasms

Case-Control Studies

Genes, BRCA1

Antineoplastic Agents, Hormonal

Tumor Cells, Cultured

Myeloproliferative Disorders

Mammary Neoplasms, Experimental

Antineoplastic Agents

Liver Neoplasms

Neoplasms, Radiation-Induced

Antigens, Neoplasm

Retrospective Studies

Postmenopause

Fibroadenoma

Parotid Neoplasms

Chemotherapy, Adjuvant

Mastectomy, Segmental

Milk, Human

Cystadenoma

Mammaplasty

Neoplasms, Connective and Soft Tissue

Neoplasms, Plasma Cell

Breast Cyst

Appendiceal Neoplasms

Carcinoma in Situ

Neoplasms, Experimental

Nipples

Treatment Outcome

Estrogens

Biopsy, Needle

Cell Proliferation

Estrogen Receptor alpha

Carcinoma, Papillary

Gastrointestinal Neoplasms

Follow-Up Studies